Hedge Fund - DAFNA Capital Management
Achillion Pharmaceuticals Inc (ACHN)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2020 - Q1 (2020-03-31) | $0 | 0% | 0 | $6.22 |
2 | 2019 - Q4 (2019-12-31) | $2,646,000 | 0.9% | 438,884 | $5.79 |
3 | 2019 - Q3 (2019-09-30) | $1,580,000 | 0.59% | 438,884 | $3.86 |
4 | 2019 - Q2 (2019-06-30) | $1,621,000 | 0.6% | 604,884 | $2.95 |
5 | 2019 - Q1 (2019-03-31) | $1,839,000 | 0.79% | 621,182 | $2.46 |
6 | 2018 - Q4 (2018-12-31) | $1,002,000 | 0.49% | 630,182 | $2.83 |
7 | 2018 - Q3 (2018-09-30) | $3,119,000 | 1.28% | 847,636 | $2.98 |
8 | 2018 - Q2 (2018-06-30) | $2,682,000 | 1.25% | 947,636 | $3.41 |
9 | 2018 - Q1 (2018-03-31) | $3,221,000 | 1.56% | 868,272 | $3.27 |
10 | 2017 - Q4 (2017-12-31) | $2,731,000 | 1.47% | 948,272 | $3.63 |
11 | 2017 - Q3 (2017-09-30) | $3,225,000 | 2% | 718,272 | $4.44 |
12 | 2017 - Q2 (2017-06-30) | $1,223,000 | 0.87% | 266,500 | $4.02 |
13 | 2017 - Q1 (2017-03-31) | $827,000 | 0.69% | 196,500 | $4.15 |
14 | 2016 - Q4 (2016-12-31) | $812,000 | 0.71% | 196,500 | $5.32 |
15 | 2016 - Q3 (2016-09-30) | $1,511,000 | 1.05% | 186,500 | $8.50 |
16 | 2016 - Q2 (2016-06-30) | $1,845,000 | 1.46% | 236,500 | $8.58 |
17 | 2016 - Q1 (2016-03-31) | $1,826,000 | 1.57% | 236,500 | $7.32 |
18 | 2015 - Q4 (2015-12-31) | $2,552,000 | 2.27% | 236,500 | $9.09 |
19 | 2015 - Q3 (2015-09-30) | $3,319,000 | 3.29% | 480,300 | $8.15 |
20 | 2015 - Q2 (2015-06-30) | $4,255,000 | 3.59% | 480,300 | $9.46 |
21 | 2015 - Q1 (2015-03-31) | $2,382,000 | 1.82% | 241,600 | $12.49 |
22 | 2014 - Q4 (2014-12-31) | $2,419,000 | 1.91% | 197,500 | $12.21 |
23 | 2014 - Q3 (2014-09-30) | $259,000 | 0.26% | 26,000 | $9.28 |
24 | 2013 - Q4 (2013-12-31) | $0 | 0% | 0 | $2.90 |
25 | 2013 - Q3 (2013-09-30) | $368,000 | 0.4% | 121,800 | $6.85 |
26 | 2013 - Q2 (2013-06-30) | $996,000 | 1.45% | 121,800 | $7.63 |
27 | 2013 - Q1 (2013-03-31) | $1,022,000 | 1.65% | 116,800 | $9.04 |
28 | 2012 - Q4 (2012-12-31) | $1,064,000 | 1.67% | 132,800 | $8.88 |
29 | 2012 - Q3 (2012-09-30) | $1,371,000 | 2.12% | 131,800 | $7.10 |
30 | 2012 - Q1 (2012-03-31) | $712,000 | 1.11% | 74,300 | $10.30 |
31 | 2011 - Q4 (2011-12-31) | $449,000 | 0.89% | 58,900 | $6.24 |
32 | 2011 - Q3 (2011-09-30) | $417,000 | 0.83% | 88,400 | $6.32 |
33 | 2011 - Q2 (2011-06-30) | $562,000 | 0.81% | 75,500 | $6.41 |
The displayed share prices are average quarterly stock market prices.